Methods of encapsulating cells
First Claim
Patent Images
1. A method of treating isolated pancreatic islet cells, comprising:
- (a) culturing said cells in a medium containing at least one compound selected from the group consisting of an antioxidant, an anti-cytokine, an anti-endotoxin, and an antibiotic;
then (b) microencapsulating said cells in a biocompatible microcapsule comprising a hydrogel core and a semipermeable outer membrane, to provide a microcapsule containing living cells therein.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods of treating and forming biocompatible microcapsules that contain living cells are provided, to improve the function of the microcapsules. In particular, methods of treating islet cells or microcapsules containing islet cells are provided. Culture of isolated islet cells prior to encapsulation, culture of encapsulated cells, and cryopreservation of islet cells prior to encapsulation, are described. Methods for harvesting viable islets that incorporates an anti-oxidant in the digestion medium are also disclosed.
14 Citations
83 Claims
-
1. A method of treating isolated pancreatic islet cells, comprising:
-
(a) culturing said cells in a medium containing at least one compound selected from the group consisting of an antioxidant, an anti-cytokine, an anti-endotoxin, and an antibiotic;
then(b) microencapsulating said cells in a biocompatible microcapsule comprising a hydrogel core and a semipermeable outer membrane, to provide a microcapsule containing living cells therein. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71)
-
-
14. A method of treating isolated pancreatic islet cells, comprising
(a) cryopreserving said cells in a cryopreservation medium comprising at least one compound selected from the group consisting of an antioxidant, an anti-cytokine, an anti-endotoxin, and an antibiotic; - then
(b) thawing said cells, and (c) encapsulating said cells in a biocompatible microcapsule comprising a hydrogel core and a semipermeable outer membrane, to provide a microcapsule containing living cells therein.
- then
-
30. A method of treating biocompatible microcapsules containing mammalian cells, wherein said microcapsule comprises a hydrogel core and a semipermeable outer membrane, comprising:
(a) culturing said microcapsules in a medium comprising at least one compound selected from the group consisting of an antioxidant, an anti-cytokine, an anti-endotoxin, and an antibiotic. - View Dependent Claims (31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 54, 55, 56, 59, 60, 61, 72, 73, 74, 75, 76)
-
41. A method according to 40 wherein said internal cell-containing core of alginate is gelled.
-
47. A method of preparing microencapsulated pancreatic islet cells comprising:
-
(a) culturing pancreatic islet cells in a first cell culture medium comprising at least one compound selected from the group consisting of;
antioxidants, anti-cytokines, anti-endotoxins, and antibiotics;
then(b) encapsulating pancreatic islet cells in a biocompatible microcapsule comprising a hydrogel core and a semipermeable outer membrane, where said islet cells are present in said core, and (c) culturing said microcapsule in a second medium comprising at least one compound selected from the group consisting of an antioxidant, an anti-cytokine, an anti-endotoxin, and an antibiotic.
-
-
57. A method according to 56 wherein said internal cell-containing core of alginate is gelled.
-
58. A method according to 56 wherein said internal cell-containing core of alginate is not gelled.
- 77. A microencapsulated islet cell product comprising microcapsules containing isolated living pancreatic islet cells therein, said microcencapsulated islet cells exhibiting a weight gain of not more than 10 percent by weight over a period of one month in physiological saline solution at 37 degrees Celsius (exhibiting the durability thereof) and exhibiting at least 150 percent basal insulin secretion in response to 16.7 milliMolar glucose challenge in Krebs-Ringer physiological solution at pH 7.4 after said period of one month.
-
78. A method of isolating pancreatic islet cells, comprising:
-
(a) digesting pancreatic tissue with a digestion medium, said digestion medium containing an antioxidant, said digesting step carried out for a time sufficient to produce free pancreatic islet cells; and
then(b) collecting said free pancreatic islet cells to produce isolated pancreatic islet cells.
-
Specification